Johnson & Johnson to Participate in the Leerink Partners 6th Annual Global Healthcare Conference
Get Alerts JNJ Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2%
Revenue Growth %: +5.5%
Join SI Premium – FREE
NEW BRUNSWICK, N.J., Jan. 23, 2017 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Leerink Partners 6th Annual Global Healthcare Conference on Thursday, Feb. 16, at Lotte New York Palace, NY. Joaquin Duato, Executive Vice President, Worldwide Chairman, Pharmaceuticals will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time).
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
A webcast and podcast replay will be available approximately two hours after the live webcast.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-leerink-partners-6th-annual-global-healthcare-conference-300394721.html
SOURCE Johnson & Johnson
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Johnson & Johnson to present neuropsychiatry data at Psych Congress 2026
- The Inner Circle acknowledges Michelle Bishop as a Pinnacle Professional Member Inner Circle of Excellence
- Medicure Presents MEND-PNPO Phase 3 Study Design and Baseline Data at the 16th European Epilepsy Congress
Create E-mail Alert Related Categories
Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share